Articles From: China Automotive Systems Completes Sale of Idle Land with a Gain of $5 Million in Net Income to China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results


WUHAN, China , June 23, 2014 /PRNewswire-FirstCall/ -- China Automotive Systems, Inc. ("CAAS" or the "Company") (NASDAQ: CAAS) , a leading power steering components and systems supplier in China , announced today that it has received cash of RMB 40 million ( $6.4 million ) in June 2014 and expects to receive cash of approximately RMB 12 million ( $1.9 million ) in July 2014 from the Jingzhou Land Reserve Center, a local PRC government bureau.
Sign-up for China Automotive Systems Completes Sale of Idle Land with a Gain of $5 Million in Net Income investment picks
WUHAN, China , Aug.
Sign-up for China Automotive Systems Reports 18% Growth in 2014 Second Quarter Sales investment picks
- Transactions Will Be Immediately Accretive to Earnings Per Share - WUHAN, China , Aug.
Sign-up for China Automotive Systems to Acquire Remaining Shares of Two Key Subsidiaries investment picks
-Teleconference to be held at 8:00 A.M. EDT/8:00 P.M. Beijing Time- WUHAN, China , July 30 , 2014 /PRNewswire/ -- China Automotive Systems, Inc. (NASDAQ: CAAS) , a leading power steering components and systems supplier in China, today announced that it will issue financial results for the 2014 second quarter and six months ended June 30, 2014 on Wednesday, August 13, 2014, before the market opens.
Sign-up for China Automotive Systems To Announce 2014 Second Quarter Financial Results on August 13, 2014 investment picks
2014/7/28
Working together to tackle core technologies and key materials and jointly training postgraduates and doctors in the battery sector.
Sign-up for China BAK Joins Hands with Dalian Institute of Chemical Physics of Chinese Academy of Sciences in Leading EV Battery Technological Revolution investment picks
2014/6/23
BEIJING , June 23, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China , today announced that on June 18, 2014 , the Ministry of Finance of China and the State Administration of Taxation of China jointly published a notice to reduce and unify the value added tax ("VAT") rate on sales of a wide range of products in China , which will take effect on July 1, 2014 .
Sign-up for China Biologic Announces Favorable Reduction in Value Added Tax Rate investment picks
2014/6/27
BEIJING , June 27, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading plasma-based biopharmaceutical company in China , today announced the pricing of a follow-on offering of 1,550,000 shares of common stock at a public offering price of $38.00 per share.
Sign-up for China Biologic Announces Pricing of Public Offering of Common Stock investment picks
2014/9/4
BEIJING , Sept.
Sign-up for China Biologic Completes Transaction to Acquire Additional Equity Stake in Guizhou Taibang investment picks
2014/8/5
2Q14 Total Sales Increase 12.1% to $60.1Million 2Q14 Operating Margin Increases to 48.1% from 47.2% 2Q14 Non-GAAP Net Income Increases 17.9% to $20.5 Million BEIJING , Aug.
Sign-up for China Biologic Reports Financial Results for the Second Quarter of 2014 investment picks
2014/8/25
BEIJING , Aug.
Sign-up for China Biologic to Increase Equity Stake in Guizhou Taibang investment picks
2014/9/5
BEIJING , Sept.
Sign-up for China Biologic to Participate in Upcoming Investor Conferences investment picks
2014/7/29
BEIJING , July 29, 2014 /PRNewswire/ -- China Biologic Products, Inc. (NASDAQ: CBPO, "China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China , today announced that the Company plans to release second quarter 2014 financial results on Tuesday, August 5, 2014 after the market closes.
Sign-up for China Biologic to Report Second Quarter 2014 Financial Results investment picks
By Eva Dou BEIJING --
Sign-up for China calls Apple's iPhone a security threat investment picks
2014/8/11
JINJIANG, China, Aug.
Sign-up for China Ceramics Announces First Quarter 2014 Financial Results investment picks
2014/7/10
JINJIANG , Fujian Province , China , July 10, 2014 /PRNewswire/ -- China Ceramics Co., Ltd.
Sign-up for China Ceramics Announces Payment Date of Semi-Annual Cash Dividend investment picks
2014/8/18
JINJIANG, China , Aug.
Sign-up for China Ceramics Announces Second Quarter 2014 Financial Results investment picks
2014/7/31
-- First and Second Quarter Results Expected to be Released on or About August 15, 2014 JINJIANG , Fujian Province , China , July 31, 2014 /PRNewswire/ -- China Ceramics Co., Ltd.
Sign-up for China Ceramics Files its Annual Report on Form 20-F for the Fiscal Year Ended December 31, 2013 investment picks
2014/8/13
Earnings Conference Call to be held on Monday, August 18, 2014 at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm (Beijing / Hong Kong) JINJIANG, China , Aug.
Sign-up for China Ceramics Schedules Second Quarter 2014 Earnings Conference Call investment picks
2014/8/28
BEIJING--China Citic Bank Corp.'s (0998.HK) first-half net profit rose 8% from the same period a year earlier, driven by higher interest income and strong growth in commission fees, it said Thursday.
Sign-up for China Citic Bank 1st Half Net Profit Up 8% at 22.03 Billion Yuan investment picks
2014/8/19
By Jeffrey Ng Midsize lender China Citic Bank Corp.
Sign-up for China Citic Bank Plans to Raise CNY37 Billion in Bond Offering investment picks
2014/8/29
BEIJING--China Construction Bank Corp.
Sign-up for China Construction Bank 1st-Half Net Profit 130.66 Billion Yuan investment picks
http://media.marketwire.com/attachments/201001/687_Juniper_logo_95.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1127833&ProfileId=051205&sourceType=1 BEIJING, CHINA --
Sign-up for China Construction Bank Secures Its Next Generation Data Centers With Juniper Networks investment picks
2014/7/23
HONG KONG , July 23, 2014 /PRNewswire-FirstCall/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, and Cordlife Group Limited (" Cordlife "), a multi-product healthcare company catering to the mother and child segment, today announced that the two companies have joined forces in assisting patients across the PRC, Singapore , Hong Kong , Indonesia , India , the Philippines and Malaysia to identify suitable cord blood matching units for stem cell therapy.
Sign-up for China Cord Blood Corporation and Cordlife Group Limited Announce Collaboration to Aid Asia-based Patients with Cord Blood Stem Cell Therapy investment picks
2014/7/31
HONG KONG , July 31, 2014 /PRNewswire/ --
Sign-up for China Cord Blood Corporation Files Its Annual Report on Form 20-F investment picks
2014/6/18
4Q14 Added 17,136 New Subscribers 4Q14 Revenue Increased to RMB151.9 Million 4Q14 Gross Profit Up 17.4% YOY to RMB124.6 Million Conference Call to be Held on June 19, 2014 at 8:00 a.m. ET Research and Development Expenses.
Sign-up for China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2014 investment picks
2014/8/28
1Q15 Added 15,548 New Subscribers 1Q15 Revenue Up 19.1% YOY to RMB153.3 Million ($24.7 Million) 1Q15 Operating Income Up 31.1%YOY to RMB60.2 Million ($9.7 Million) Conference Call to be Held August 29, 2014 at 8:00 a.m. ET HONG KONG , Aug.
Sign-up for China Cord Blood Corporation Reports First Quarter Fiscal 2015 Financial Results investment picks
2014/9/5
HONG KONG , Sept.
Sign-up for China Cord Blood Corporation to Incentivize Management Team with Share Awards investment picks
2014/8/21
Earnings Call Scheduled for 8:00 a.m. ET on August 29, 2014 HONG KONG , Aug.
Sign-up for China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: China Automotive Systems Completes Sale of Idle Land with a Gain of $5 Million in Net Income to China Cord Blood Corporation to Report First Quarter of Fiscal 2015 Financial Results
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices